400 Million Tubes/Year Capacity Goal and a 100+ Product Roadmap

In Phase 1, SEM Biotech targets a production capacity of 384,000,000 tubes per year. With continued investment, we plan to expand capacity further while introducing additional product types selected to meet market needs.

Our portfolio includes multiple tube types such as serum tubes, serum tubes with gel (SST), K2/K3 EDTA tubes, lithium/sodium heparin tubes, and non-additive blood collection tubes, along with size options aligned with laboratory workflows.